Aminopyrimidines useful as kinase inhibitors

Details for Australian Patent Application No. 2006311797 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Robinson, Daniel; O'Donnell, Michael; Studley, John; Davis, Chris; Rutherford, Alistair; Mortimore, Michael; Binch, Hayley; Pinder, Joanne; Everitt, Simon; Ramaya, Sharn; Milier, Andrew; Fraysse, Damien; Boyall, Dean

Agent Peter Maxwell & Associates

Pub. Number AU-A-2006311797

PCT Pub. Number WO2007/056221

Priority 60/732,951 03.11.05 US; 60/733,557 04.11.05 US

Filing date 3 November 2006

Wipo publication date 18 May 2007

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

C07D 239/02 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/056221 Priority application(s): WO2007/056221

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311803-Use of complement pathway inhibitors to treat ocular diseases

2006311796-5-lipoxygenase-activating protein (FLAP) inhibitors